Received Oct 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RVX | ROTAVIRUS (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
Ended in hospital for 8 days with Pneumonia; This serious case was reported by a consumer via interactive digital media and described the occurrence of pneumonia in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced pneumonia (Verbatim: Ended in hospital for 8 days with Pneumonia) (serious criteria hospitalization and GSK medically significant). The outcome of the pneumonia was not reported. It was unknown if the reporter considered the pneumonia to be related to RSV vaccine. The company considered the pneumonia to be unrelated to RSV vaccine. Additional Information: GSK Receipt Date: 24-OCT-2025 This case was reported by a patient via interactive digital media. The patient stated that the patient will never get it again. The batch number was not provided, and unable to contact the reporter.; Sender's Comments: A case of Pneumonia, on an unkonwn time after receiving RSV vaccine, in a patient. Based on the available information a possible causality that the event(s) was caused by the GSK product cannot be ascertained. Consent for further follow up has not been received.